Amundi’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$539K Buy
+9,749
New +$464K ﹤0.01% 1521
2025
Q2
Sell
-6,903
Closed -$140K 2035
2025
Q1
$140K Sell
6,903
-2,952
-30% -$66K ﹤0.01% 1712
2024
Q4
$212K Buy
9,855
+6,403
+185% +$148K ﹤0.01% 1720
2024
Q3
$76K Buy
3,452
+783
+29% +$15.1K ﹤0.01% 1804
2024
Q2
$45.7K Sell
2,669
-941
-26% -$15.1K ﹤0.01% 1799
2024
Q1
$47.1K Buy
3,610
+1,268
+54% +$15.2K ﹤0.01% 1847
2023
Q4
$26.3K Hold
2,342
﹤0.01% 1936
2023
Q3
$27.6K Sell
2,342
-562
-19% -$7.97K ﹤0.01% 1909
2023
Q2
$40K Buy
2,904
+136
+5% +$1.95K ﹤0.01% 1917
2023
Q1
$40.5K Sell
2,768
-15,106
-85% -$231K ﹤0.01% 1906
2022
Q4
$260K Buy
+17,874
New +$240K ﹤0.01% 1484
2022
Q3
Sell
-1,572
Closed -$30K 1888
2022
Q2
$30K Sell
1,572
-577
-27% -$10.9K ﹤0.01% 1576
2022
Q1
$43K Sell
2,149
-153,329
-99% -$3.1M ﹤0.01% 1547
2021
Q4
$3.17M Sell
155,478
-43,151
-22% -$921K ﹤0.01% 1114
2021
Q3
$4.28M Sell
198,629
-273,792
-58% -$6.59M ﹤0.01% 1045
2021
Q2
$13.6M Buy
+472,421
New +$12.8M 0.01% 761

Other funds holding PAHC

Amundi's PAHC Position: Q1 2026 in Review

Amundi opened a new position in Phibro Animal Health (PAHC) in Q1 2026: 9,749 shares worth $539K. The stake represents ﹤0.01% of the portfolio and ranks #1521 among its holdings. This is a return to the name: Amundi previously reported a position in PAHC as recently as Q1 2025.

Amundi first reported a position in PAHC in Q2 2021 and has held it in 16 quarters since. The position peaked at $13.6M in Q2 2021. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Amundi held 9,749 shares of Phibro Animal Health worth $539K as of Q1 2026.
  • Phibro Animal Health was a new Amundi position in Q1 2026.
  • Phibro Animal Health made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1521 holding.
  • Amundi first reported a position in Phibro Animal Health in Q2 2021 and has held it in 16 quarters since.
  • Amundi's Phibro Animal Health position peaked at $13.6M in Q2 2021.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.